Moderna
MRNA
#1185
Rank
C$22.07 B
Marketcap
$57.37
Share price
0.98%
Change (1 day)
-54.39%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2024 (TTM): -C$3.18 Billion

According to Moderna 's latest financial reports the company's current earnings are C$5.05 Billion. In 2023 the company made an earning of -C$5.64 Billion a decrease over its 2022 earnings that were of C$13.85 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$3.18 Billion-43.61%
2023 -C$5.64 Billion-140.65%
2022 C$13.85 B-27.81%
2021 C$19.18 B-1911.15%
2020 -C$1.06 Billion44.7%
2019 -C$0.74 Billion28.63%
2018 -C$0.57 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$59.68 Million-98.22%๐Ÿ‡บ๐Ÿ‡ธ USA
C$21.59 B-742.89%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$60.24 Million-98.21%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.27 Billion-91.98%๐Ÿ‡บ๐Ÿ‡ธ USA
C$18.36 B-646.67%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-C$0.84 Billion-75.09%๐Ÿ‡บ๐Ÿ‡ธ USA
C$26.53 B-889.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.17 Billion-94.95%๐Ÿ‡บ๐Ÿ‡ธ USA